Defining the Phenotype in Congenital Disorder of Glycosylation Due to <i>ALG1</i> Mutations
Éva Morava(Institut thématique Génétique, génomique et bioinformatique), Ron A. Wevers(Radboud University Nijmegen), Ivana Mihalek(Boston Children's Hospital), Sylvia Stöckler(University of British Columbia), Zong H. Zhang(Bioinformatics Institute), Ludwig Lehle(University of Regensburg), Julia Vodopiutz(Medical University of Vienna), Andreas Janecke(Innsbruck Medical University), Chike Bellarmine Item(Medical University of Vienna), Wolfgang M. Schmidt(Medical University of Vienna), Jolanta Sykut‐Cegielska, Olaf A. Bodamer(Broad Institute), Maciej Adamowicz(Children's Memorial Health Institute), Silvia Lechner(Innsbruck Medical University), Dirk J. Lefeber(Radboud University Nijmegen), Jolanta Wierzba(Gdańsk Medical University)
Cited by 43
Related Papers
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|823
GJB2 Mutations and Degree of Hearing Loss: A Multicenter Study
|The American Journal of Human Genetics|2005|562
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy
|European Journal of Pediatrics|2007|535
Mutations in the JARID1C Gene, Which Is Involved in Transcriptional Regulation and Chromatin Remodeling, Cause X-Linked Mental Retardation
|The American Journal of Human Genetics|2005|376
Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism–dystonia
|Nature Communications|2016|326